JIANG, Guangcheng,RABINOVICH, Aleksandr,SUEIRAS-DIAZ, Javier,WISNIEWSKI, Kazimierz
申请号：
TN2017000248
公开号：
TN2017000248A1
申请日:
2016.01.06
申请国别(地区):
TN
年份:
2018
代理人:
摘要：
This disclosure relates to compounds of formula (I) or a pharmaceutically acceptable salt thereof: in which m, p, A, Ar<；sup>；1<；/sup>；, Ar<；sup>；2<；/sup>；, Ar<；sup>；3<；/sup>；, R<；sup>；1<；/sup>；, R<；sup>；2<；/sup>；, and R<；sup>；3<；/sup>； are defined in the specification. The compounds of formula (I) can be used as CGRP antagonists and can be used to treat migrane.
